D. E. Shaw & Co., Inc. Biogen Inc. Put Options Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

Put Options

24 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$189.07 - $236.8 $3.14 Million - $3.93 Million	-16,600 Reduced 48.82%	17,400 $3.37 Million
Q2 2024 Aug 14, 2024	BUY	$190.52 - $236.72 $3.54 Million - $4.4 Million	18,600 Added 120.78%	34,000 $7.88 Million
Q1 2024 May 15, 2024	BUY	$212.02 - $267.71 $1.67 Million - $2.11 Million	7,900 Added 105.33%	15,400 $3.32 Million
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $16.3 Million - $18.6 Million	-63,500 Reduced 89.44%	7,500 $2.09 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $22.4 Million - $30.9 Million	-115,000 Reduced 61.83%	71,000 $19 Million
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $2.29 Million - $2.88 Million	11,800 Added 6.77%	186,000 $39.2 Million
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $15 Million - $19.2 Million	66,800 Added 62.2%	174,200 $41.8 Million
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $5.24 Million - $6.83 Million	-18,500 Reduced 14.69%	107,400 $30.4 Million
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $9.71 Million - $15.6 Million	37,500 Added 42.42%	125,900 $43.6 Million
Q1 2021 May 17, 2021	SELL	$242.95 - $284.63 $10.2 Million - $11.9 Million	-41,800 Reduced 32.1%	88,400 $24.7 Million
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $11.5 Million - $17.4 Million	48,800 Added 59.95%	130,200 $31.9 Million
Q3 2020 Nov 16, 2020	SELL	$264.77 - $305.71 $3.2 Million - $3.7 Million	-12,100 Reduced 12.94%	81,400 $23.1 Million
Q2 2020 Aug 14, 2020	BUY	$258.66 - $342.55 $8.85 Million - $11.7 Million	34,200 Added 57.67%	93,500 $25 Million
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $21.1 Million - $26.7 Million	-78,400 Reduced 56.94%	59,300 $18.8 Million
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $2.2 Million - $3.04 Million	-10,000 Reduced 6.77%	137,700 $40.9 Million
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $1.67 Million - $1.88 Million	7,700 Added 5.5%	147,700 $34.4 Million
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $15.4 Million - $16.9 Million	70,000 Added 100.0%	140,000 $32.7 Million
Q1 2019 May 15, 2019	SELL	$216.71 - $338.96 $22.6 Million - $35.4 Million	-104,300 Reduced 59.84%	70,000 $16.5 Million
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $8.36 Million - $10.6 Million	30,000 Added 20.79%	174,300 $52.5 Million
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $7.19 Million - $9.4 Million	24,500 Added 20.45%	144,300 $51 Million
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $14 Million - $16.7 Million	54,500 Added 83.46%	119,800 $34.8 Million
Q1 2018 May 15, 2018	SELL	$260.13 - $367.91 $3.98 Million - $5.63 Million	-15,300 Reduced 18.98%	65,300 $17.9 Million
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $3.63 Million - $4.07 Million	-11,800 Reduced 12.77%	80,600 $25.7 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $26 Million - $30.5 Million	92,400	92,400 $28.9 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.6B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account